[go: up one dir, main page]

HUP9700806A2 - Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására - Google Patents

Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására

Info

Publication number
HUP9700806A2
HUP9700806A2 HU9700806A HUP9700806A HUP9700806A2 HU P9700806 A2 HUP9700806 A2 HU P9700806A2 HU 9700806 A HU9700806 A HU 9700806A HU P9700806 A HUP9700806 A HU P9700806A HU P9700806 A2 HUP9700806 A2 HU P9700806A2
Authority
HU
Hungary
Prior art keywords
matrix tablet
sodium salt
tianeptine
preparation
prolonged release
Prior art date
Application number
HU9700806A
Other languages
English (en)
Inventor
Bruno Huet De Barochez
Patrick Wüthrich
Original Assignee
Adir Et Compagnie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir Et Compagnie filed Critical Adir Et Compagnie
Publication of HU9700806D0 publication Critical patent/HU9700806D0/hu
Publication of HUP9700806A2 publication Critical patent/HUP9700806A2/hu
Publication of HUP9700806A3 publication Critical patent/HUP9700806A3/hu
Publication of HU224192B1 publication Critical patent/HU224192B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A találmány tárgya tianeptin-nátriűmsó nyújtőtt felszabadűlásátbiztősító mátrixtabletta, mely galenikűs főrmában őrális útőn adhatóbe, és felszívódás űtán a vérben állandó és egyenletes kőncentrációtbiztősít. A találmány tárgya tővábbá eljárás a mátrixtabletta előállítására. Atianeptin elsősőrban szőrőngás és depresszió kezelésére alkalmas. ŕ
HU9700806A 1996-04-24 1997-04-24 Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására HU224192B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605174A FR2747921B1 (fr) 1996-04-24 1996-04-24 Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale

Publications (4)

Publication Number Publication Date
HU9700806D0 HU9700806D0 (en) 1997-06-30
HUP9700806A2 true HUP9700806A2 (hu) 1998-10-28
HUP9700806A3 HUP9700806A3 (en) 2000-01-28
HU224192B1 HU224192B1 (hu) 2005-06-28

Family

ID=9491549

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700806A HU224192B1 (hu) 1996-04-24 1997-04-24 Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására

Country Status (18)

Country Link
US (1) US5888542A (hu)
EP (1) EP0803253B1 (hu)
JP (1) JPH1036268A (hu)
CN (1) CN1116029C (hu)
AT (1) ATE205715T1 (hu)
AU (1) AU719822B2 (hu)
CA (1) CA2203310C (hu)
DE (1) DE69706748T2 (hu)
DK (1) DK0803253T3 (hu)
ES (1) ES2164310T3 (hu)
FR (1) FR2747921B1 (hu)
GR (1) GR3037043T3 (hu)
HU (1) HU224192B1 (hu)
NO (1) NO315407B1 (hu)
NZ (1) NZ314662A (hu)
PL (1) PL188135B1 (hu)
PT (1) PT803253E (hu)
ZA (1) ZA973495B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791891A1 (fr) * 1999-04-07 2000-10-13 Adir Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
EP1575565B1 (en) * 2003-08-08 2010-01-06 Biovail Laboratories International Srl Modified-release tablet of bupropion hydrochloride
US20050227961A1 (en) * 2004-04-08 2005-10-13 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
US9314469B2 (en) 2008-05-05 2016-04-19 Tonix Pharma Holdings Limited Method for treating neurocognitive dysfunction
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
WO2010138796A2 (en) * 2009-05-29 2010-12-02 Genomind, Llc Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
KR20120092993A (ko) * 2011-02-14 2012-08-22 지엘팜텍 주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
PL2561864T3 (pl) * 2011-08-25 2015-05-29 Zakl Farmaceutyczne Polpharma Sa Tabletka powlekana zawierająca tianeptynę i sposób jej otrzymywania
KR101136976B1 (ko) * 2011-09-06 2012-05-30 건일제약 주식회사 티아넵틴 또는 그의 염을 포함하는 탈모증의 예방 또는 치료용 약학 조성물
GB201208315D0 (en) 2012-05-11 2012-06-27 Numedicus Ltd Pharmaceutical methods and compositions
CN104031005B (zh) * 2014-05-30 2016-04-27 济南诚汇双达化工有限公司 一种噻萘普汀钠中间体的制备方法
KR20180101307A (ko) 2018-09-04 2018-09-12 지엘팜텍주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR20200104265A (ko) 2020-08-21 2020-09-03 지엘팜텍주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
WO2024206520A1 (en) 2023-03-27 2024-10-03 Tonix Pharmaceuticals Holding Corp. (s)-tianeptine and use in treating disorders and conditions associated with peroxisome proliferator-activated receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
FR2635461B1 (fr) * 1988-08-18 1992-01-17 Adir Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.

Also Published As

Publication number Publication date
NO971860L (no) 1997-10-27
CA2203310A1 (fr) 1997-10-24
PT803253E (pt) 2001-12-28
AU1904197A (en) 1997-10-30
CN1116029C (zh) 2003-07-30
ATE205715T1 (de) 2001-10-15
NZ314662A (en) 1998-12-23
US5888542A (en) 1999-03-30
DE69706748D1 (de) 2001-10-25
JPH1036268A (ja) 1998-02-10
PL188135B1 (pl) 2004-12-31
NO971860D0 (no) 1997-04-23
FR2747921A1 (fr) 1997-10-31
GR3037043T3 (en) 2002-01-31
HU224192B1 (hu) 2005-06-28
HUP9700806A3 (en) 2000-01-28
CA2203310C (fr) 2001-10-23
CN1168792A (zh) 1997-12-31
DK0803253T3 (da) 2001-11-19
ES2164310T3 (es) 2002-02-16
EP0803253A1 (fr) 1997-10-29
FR2747921B1 (fr) 1998-10-30
HU9700806D0 (en) 1997-06-30
AU719822B2 (en) 2000-05-18
NO315407B1 (no) 2003-09-01
EP0803253B1 (fr) 2001-09-19
DE69706748T2 (de) 2002-07-04
ZA973495B (en) 1997-11-18
PL319627A1 (en) 1997-10-27

Similar Documents

Publication Publication Date Title
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
HUP9800794A2 (hu) (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása
DK0678023T3 (da) Anvendelse af riluzol ved fremstilling af lægemidler til behandling af Parkinsons sygdom og parkinsonisme-syndromer
EE200000503A (et) Meetod topiramaadi farmatseutilise kompositsioonivalmistamiseks, farmatseutiline kompositsioon ning topiramaadi kasutamine diabeedi raviks ette nähtud ravimi valmistamiseks
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
EE04417B1 (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
NO985464L (no) Konsentrert antistoffpreparat
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
NO20010277D0 (no) Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
BR9811086A (pt) Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica
FI935693A7 (fi) Bifenyylin johdannaiset, niiden valmistus ja käyttö korkean verenpaineen ja sydäntautien hoitoon
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
HUP9800198A2 (hu) 1-{4-[4-Aril-(vagy -heteroaril)-1-piperazinil]-butil}-1H-azol-származékok alkalmazása gyógyszerkészítmények előállítására
MXPA04001912A (es) Aminobenzofenonas novedosas.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050420

MM4A Lapse of definitive patent protection due to non-payment of fees